The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

@article{Vardiman2009The2R,
  title={The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.},
  author={James W. Vardiman and J{\"u}ergen Thiele and Daniel Alan Arber and Richard D. Brunning and Michael J. Borowitz and Anna A Porwit and Nancy Lee Harris and Michelle M Le Beau and Eva Hellstr{\"o}m-Lindberg and Ayalew Tefferi and Clara D. Bloomfield},
  journal={Blood},
  year={2009},
  volume={114 5},
  pages={
          937-51
        }
}
Recently the World Health Organization (WHO), in collaboration with the European Association for Haematopathology and the Society for Hematopathology, published a revised and updated edition of the WHO Classification of Tumors of the Hematopoietic and Lymphoid Tissues. The 4th edition of the WHO classification incorporates new information that has emerged from scientific and clinical studies in the interval since the publication of the 3rd edition in 2001, and includes new criteria for the… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 1,510 CITATIONS

Biphenotypic acute leukemia or acute leukemia of ambiguous lineage in childhood: clinical characteristics and outcome

  • Blood research
  • 2019
VIEW 8 EXCERPTS
CITES METHODS, RESULTS & BACKGROUND
HIGHLY INFLUENCED

Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation

  • The Journal of experimental medicine
  • 2018
VIEW 4 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Practical Guide to Bone Marrow Sampling for Suspected Myelodysplastic Syndromes

  • Journal of the advanced practitioner in oncology
  • 2017
VIEW 7 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.

  • Clinical lymphoma, myeloma & leukemia
  • 2016
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Tea consumption reduces the risk of de novo myelodysplastic syndromes.

VIEW 6 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Clinical characteristics and prognosis of nonleukemic myeloid sarcoma.

  • The American journal of the medical sciences
  • 2014
VIEW 5 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2008
2019

CITATION STATISTICS

  • 152 Highly Influenced Citations

  • Averaged 180 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 121 REFERENCES

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

A gain-of-function mutation of JAK2 in myeloproliferative disorders.

  • The New England journal of medicine
  • 2005
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

JAK2 mutations in myeloproliferative disorders.

  • The New England journal of medicine
  • 2005
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues

ES Jaffe, NL Harris, H Stein
  • 2001
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…